Biotecnika newspaper 19th dec 2017

December 19th, 2017.

Vol. 01 NO 5

NEWS - PAGE 3

NEWS - PAGE 4

DR. RITA COLWELL WINS TOP INTERNATIONAL BIOLOGY PRIZE

HEART-IN-A-JAR TO TEST NEW DRUGS

NEWS - PAGE 4

JOBS, SCHOLARSHIPS & ADMISSIONS - PAGES 6-11

NO CUT, EPIGENETIC CRISPR MENDS DEFECTIVE DNA

BIOTECNIKA STUDENTS SHINE

NEW JOBS AVAILABLE

“194+ STUDENTS IN CSIR NET JUNE 2017 EXAM HAD SHINED” These are REAL Testimonials by REAL students of BioTecNika, these toppers will now be a part of our Toppers Platform ( a platform where current students of Biotecnika interact with Toppers of the CSIR NET & GATE exam and seek guidance ) Want Admission Coaching?

to

BioTecNika’s

Call 080-6999-7000 / 1800-200-3757 Our Doors are always open for future Toppers, Want to be one?

Call us Today

By Shekhar Suman

194+ BioTecNika students shine in CSIR NET June 2017 Exam, Watch their Success Stories Dear BioTecNikans, Its indeed a happy moment, Some of you have made us so proud that we have no words left to praise. 194+ Biotecnika students have so far reported us that they have successfully qualified CSIR NET June 2017 and majority of them in the Top 100 JRF Ranks. What makes this time’s result more interesting is we saw a lot of students ( who used flash cards ) secure higher ranks.

We would take this moment to congratulate each & every one of you who made it through and would like to commit ourselves to those who would like to prepare for CSIR NET & GATE exam with us in the future.

We would like to Thank all our Hardworking Faculty Members ( spread across India in 5 cities), Non-Teaching Staff, Students & Subscribers who kept their continued faith in our Brand and this has resulted in this massive Success.

While the Testimonials Below is not just a Proof of our Quality but also the rigorous training Students undertook and underwent.

We thank the Students who took up the challenge to cope with the vast syllabus curriculum provided by BioTecNika. Not every Student can show the stamina which was shown by these toppers.

We advise all the prospective students to go through all the videos as this will help you understand the Topper Mindset Have a look at their Success Story: NB: Many students Video Success stories are still awaited since they are busy preparing for the December 2017 exam.

Many more success stories Videos have been received, however its under processing by our Team. Watch this space for more videos in the future.

GET THIS NEWSPAPER e-copy VIA WHATSAPP every week

GIVE MISSED CALL TO

080-395-34707 1

Vol. 01 NO 5

December 19th, 2017.

Nisa Roy: LS 37

Vijay Kumar: LS 74

Anikta Maurya : JRF 99

Deepika Verma: JRF 55

Bhavna Saroha: JRF 45

Deepa Yogi: JRF 52

Akshatha S : JRF 45

Asha Parveen JRF 35

Sandip Das LS 91

Subhadeep Biswas LS 100

WATCH ALL VIDEO INTERVIEWS AT http://bit.ly/csir-net-toppers 2

Vol. 01 NO 5

December 19th, 2017.

DR. RITA COLWELL WINS TOP INTERNATIONAL BIOLOGY PRIZE

By Disha Padmanabha Rita Colwell, distinguished professor in the University of Maryland’s cell biology and molecular genetics department, has been awarded the International Prize for Biology 2017 for her outstanding contributions to marine microbiology, bioinformatics, microbiomes and the understanding and prevention of cholera.

Colwell is the thirty-third recipient of the International Prize for Biology, generally recognized as one of the most prestigious honors a natural scientist can receive. Past laureates include such other renowned biologists as John B. Gurdon, Motoo Kimura, Edward O. Wilson, Ernst Mayr, and Thomas Cavalier-Smith.

There is no Nobel Prize for biology, but Japan’s International Prize for Biology is one of three prizes often considered to be biology’s equivalent. The other two honors often placed in this category are the Balzan Prize and Crafoord Prize.

The prize also recognizes Colwell’s

life-saving contributions to the understanding and prevention of cholera, an acute diarrheal disease, which, until Colwell began her work on this project in 1960, was widely believed that cholera was only transmitted from person to person. However, Colwell and her team’s research over the years have shown that it is caused by environmental factors and is associated with natural bacteria on the zooplankton.

“It is an extraordinary honor to be named recipient of the International Prize for Biology, a very special honor for a biologist,” said Colwell. “I am deeply grateful to the Japan

Society for the Promotion of Science for this award. I have many friends and colleagues in Japan and look forward to continuing my many collaborations with them.”

Colwell has received a great many awards and recognitions, including the 2017 Vannevar Bush Award given by the U.S. National Science Board; the 2010 Stockholm Water Prize awarded by the King of Sweden; the 2006 National Medal of Science awarded by the president of the United States; and the Order of the Rising Sun, Gold and Silver Star bestowed by the Emperor of Japan. She is the recipient of 61 honorary degrees from institu-

tions of higher education and has a geological site in Antarctica, Colwell Massif, named in recognition of her work in the polar regions.

Colwell was the 11th director of the National Science Foundation and the first woman to head the agency. She also co-chaired the Committee on Science, National Science and Technology Council. She has held numerous advisory positions in the U.S. government, nonprofit science policy organizations, and private foundations and has authored or co-authored 19 books and more than 800 scientific publications.

Biotech’s Next Big (Blue) Platform: Startup Secures $13M for Tech Using Algae to Make Biologics The company announced early last week that it has raised $13 million in funding to support that work, and also announced its first product, a “natural” blue colorant that it plans to launch in early 2018.

The new funds include $11.2 million in venture funding raised from Avista Development Corporation, BioEconomy Capital, and Seattle-area biotech investors, along with a $1.8 million grant Lumen received from the Department of Energy earlier this year.

Lumen was co-founded by former Adaptive Biotechnologies executive Brian Finrow and Jim Roberts, who previously directed Fred Hutchinson Cancer Center’s Basic Sciences Division. The pair believes they have found the first method to engineer spirulina to be used to create drugs. It is the first time the company has raised funds since it was founded in April of this year.

The blue colorant is manufactured using Spirulina, a bright green algae that was recently approved by the FDA to use in supplements and the manufacturing of food and cosmetics. That makes the colorant “natural”

by industry standards, as opposed to a pigment made from inorganic materials in a lab.

“For years, demand has grown for natural alternatives to food and cosmetics with artificial colors made from petroleum and coal tar, which many believe to be unhealthy,” Finrow said. “But high cost and variable quality have held back natural colors from being widely adopted. The color blue has been a particularly tough challenge, because few plants make it in harvestable quantities.

Lumen’s platform can lower cost, increase production and quality control, and unleash Spirulina extract’s enormous market potential with consumers.”

Lumen’s improved strains produce more pigment at higher purity but at a fraction of the cost of traditional methods, and without introducing foreign gene pathways from other species. More stable versions and a palette of additional colors are also in the pipeline, the company said.

By Disha Padmanabha

“We are excited to announce our series A financing, which will fully fund the commercial launch of our first product, a natural blue colorant for high-purity applications in the food and cosmetics industries,” said Brian Finrow, Lumen’s CEO and co-founder.

“Together with the federal grant we received over the summer, these funds will allow our research team to build out the complete set of microbiology tools and methods needed to unlock our platform’s vast commercial potential. Lumen is poised to have a big impact on the $1.5 billion market for natural colorants, and that’s only a small piece of the larger opportunity we and our collaborators expect to access with this new technology.”

vaccine that can be stored at higher temperatures than those currently available, making it easier to transport in warm climates.

Eventually, Lumen plans to license its spirulina technology to other companies that want to use the algae to create drugs.

The startup is already working on a malaria

3

Vol. 01 NO 5

December 19th, 2017.

Heart-In-A-Jar to Test New Drugs You probably don’t think about it as often, yet it continues to pump with its faithful, steady beat- carrying blood to all your organs. Heart is truly a wonderful organ; but how about one beating rhythmically, suspended in a jar? Bizarre? No, Amazing rather.

Canadian-backed biotech Novoheart has created stem cells, which in turn can build a blood-ejecting mini “cloned” human heart.

The potential is huge. And it’s a world first.

The first thing people say when they see the tiny hearts in action company co-founder Kevin Costa says is, “Wow, it’s actually beating.… It’s actually working like a heart.”

He says the Novoheart technology is different from other stem cell-derived testing methods because of the three-dimensional structure of his company’s “Heart-in-a-jar.” “We can actually measure the hollow chamber that is pumping, so we can monitor how much pressure the organ is generating, like the blood pressure.”

The Novoheart is an actual beating heartlike structure made of stem cells that could revolutionize the path to market for new drugs.

Creating the heart valves is a multi-step process where scientists reprogram blood cells into stem cells that are then manipulated into heart cells. Millions of these heart cells form

a Jello-O like solution that grows into a mold taking the shape of the “heart.” Once fully formed, the mini heart beats allowing scientists to measure the pace, similar to a heart rate.

The researchers involved in the company say the drugs could be tested on bio-artificial human hearts to see their impact, levels of toxicity, and side-effects. Many people who take hard-hitting cancer drugs end up with cardiovascular issues, or even die from heart failure because the drugs are so toxic.

Doctors cannot tell who is more susceptible to drug-induced heart problems. This would provide a safe environment for patients and drug companies to try out drugs.

Currently, the patients are guinea pigs, but in time, these mini-hearts could be put to work to find out both the positive and negative effects of a drug. Hundreds of thousands of mini-hearts at a time could be developed according to them and can further be personalized if need be.

Novoheart was recently listed on the TSX Venture Exchange and has received financial backing from Canadian investors.

“I think it’s a very topical and relevant industry segment,” says Darren Devine with CDM Capital Partners, which has a stake in the company. CDM invested in Novoheart because it believes companies like it can be

By Disha Padmanabha

Novoheart Pumps New Life to Drug Development Sector, “Heart-In-A-Jar” to Test New Drugs disrupters to the pharmaceutical industry.

In the stem cell industry, scaling up research into practical opportunities has been a problem, Devine says.

“What investors are looking at now is how do you take this science experiment and turn it into a commercial opportunity?”

To survive, he says companies need to prove they can get big, sustainable contracts

from pharmaceutical companies that will have commercial value on a long-term basis.

People outside the scientific community often find technology of the type that’s happening at Novoheart something of a head-scratcher. But despite still being in the early stages and futuristic by nature, it’s something already getting attention from the global pharmaceutical industry.

Researchers Uncover Advanced Cancer Resistance Pathway Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study were reported at the ESMO Immuno Oncology Congress 2017.

The discovery is based on findings from the 300-patient IMvigor210 biomarker study, the results from which led to FDA approval of the anti-PD-L1 antibody atezolizumab for the treatment of advanced bladder cancer.

“Understanding why the remaining 70% to 80% are resistant would enable us to target the mechanism with an additional drug and extend the benefits of checkpoint inhibitors to more patients,” suggests Sanjeev Mariathasan, Ph.D., senior scientist, oncology biomarker department, at Genentech.

The IMvigor210 biomarker study investigated the drivers of efficacy and primary resistance to the anti-PD-L1 checkpoint inhibitor atezolizumab in 300 patients with bladder cancer. They used a combination of methods including immunohistochemistry, genome sequencing, and RNA expression.

The researchers found two drivers of efficacy and one driver of resistance. In terms of efficacy, tumours with the highest number of mutations – called a high mutation burden – were the most amenable to immunotherapy.

Tumours that had T cells present in the tumour microenvironment were also more responsive to immunotherapy. Regarding re-

4

sistance, tumours with high expression of the cytokine TGF-β tended to be unresponsive to immunotherapy.

Mariathasan said that in “T cell excluded tumours”, the tumour may secrete a factor that builds a collagen-rich fortified wall around the tumours. The stromal microenvironment is like a Velcro that T cells stick to and do not enter the tumour. High expression of TGF-β and TGF-β-induced stromal genes in these excluded tumours were associated with non-responders, suggesting that these may help to fortify the tumour against T cell penetration.

The researchers then examined whether inhibiting TGF-β activity could improve the efficacy of atezolizumab with the help of a mouse model with the “T cell excluded tumour” phenotype which was used to compare four treatments: isotype antibody (control group), anti-PD-L1 alone, anti-TGF-β alone, and the combination of anti-TGF-β plus anti-PD-L1.

In the combination group, TGF-β activity in stromal cells was reduced, T cells penetrated into the centre of the tumour, and the tumour reduced in size.

Mariathasan said: “This suggests that giving anti-TGF-β and anti-PD-L1 together can remodel the stromal microenvironment and allow T cells into the tumour. The ‘T cell excluded’ phenotype is common in other cancers such as lung, pancreatic and colorectal,

By Disha Padmanabha

so this combination therapy could be tested in a wider group.”

When it comes to the need for further research, Professor Ignacio Melero, Senior Researcher, Centre for Applied Medical Research (CIMA), Pamplona, Spain, said: “In bladder cancer it makes sense to design and implement a clinical trial that would select patients based on a TGF-β signature and treat them with an anti-TGF-β agent plus PD-1 or PD-L1 blockade. Better anti-TGF-β agents need to be developed for use combination with immunotherapy agents.”

George Coukos, Congress Co-Chair, Professor and Director, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland, said the research had two main implications: “First of all it explains why T cells are perhaps retained in

the stroma and are not able to move into the tumour. Most importantly, it opens the door for improving therapeutic responses to PD-1/ PD-L1 blockade by simultaneously targeting the TGF-β pathway.”

Vol. 01 NO 5

December 19th, 2017.

Novozymes Teams Up With Danish Pump Producer for Safe Water Solutions Danish pump producer, Grundfos has now entered an “innovation collaboration” with Novozymes, taking place on HelloScience.io, an online universe launched by Novozymes where entrepreneurs, startups and others can connect with industry.

The collaboration is expected to help Novozymes in its quest to fight water scarcity, a major public health issue that forces at least 2 billion people around the world to use a contaminated water source.

Grundfos, a global leader in advanced pump solutions and a trendsetter in water technology will now be combining its tech with that of the biotech’s to provide cutting-edge water technology. Four specific challenges will be posted online, allowing all in the HelloScience community to pitch their ideas on how

to secure clean water for more people – and receive sparring, input and assistance from both Novozymes and Grundfos. The two companies seek solutions to remove polluting chemicals from water and improve cleaning of wastewater. That includes better filtering, less sludge, and recovery of phosphate, a precious nutrient, from wastewater.

“This is a great opportunity. Partnering with Grundfos opens new possibilities for Novozymes, the HelloScience platform and its users. Until now, we have been able to connect the startups and academics, who are part of this network, with our knowledge about enzymes and microorganisms, and allowing them to use samples in their work, but now we can also connect them with Grund-

By Disha Padmanabha

fos’ expertise in water treatment,” says Claus Crone Fuglsang, Senior Vice President, Research & Technology at Novozymes.

“This is an excellent chance to see what we can do in combination with Novozymes.

Adding biotechnology to what we can do in for instance digital dosing might very well open brand-new possibilities for e.g. wa-

ter treatment. And while we strengthen our connection with Novozymes, we also get an opportunity to review fresh takes on the water challenges from all over the world. We need new partnerships to solve these great challenges, and this is another step down that road,” says Lars Enevoldsen, Group Vice President, Technology & Innovation at Grundfos.

No-Cut, Epigenetic CRISPR Mends Defective DNA We are at a golden age of genetic engineering, where huge advances in gene-editing technology are making it possible for scientists to tweak the DNA of different organisms with incredible, unprecedented precision.

Until just a few years ago, altering individual genes in everything from plant cells to mouse cells to human cells was a crude, laborious, and often futile process.

And now here we are, as scientists use techs like CRISPR, which harnesses the immune system of bacteria to snip individual genes, either knocking them out or even inserting new ones in their place. But all good things are well… not all good- and in case of this gene editing tool, sure enough it snips DNA at precise locations, but it is also is capable of “turning up the volume” on some genes.

This potentially overcomes the problem of the wrong genes being modified by mistake, so-called off-target effects, which is viewed as a major safety barrier to using Crispr in a clinical context.

“Cutting DNA opens the door to introducing new mutations,” said Juan Carlos Izpisua Belmonte, who led the latest work at the Salk Institute in La Jolla, California. “That is something that is going to stay with us with Crispr or any other tool we develop that cuts DNA. It is a major bottleneck in the field of genetics – the possibility that the cell, after the DNA is cut, may introduce harmful mistakes.”

With that in mind, a team of researchers set out to develop a take on CRISPR-Cas9 technology that wouldn’t require the DNA to be cut at all. A trial of their technique was successfully used on mice to treat several diseases. The study proves, for the first time, that the phenotype of an animal can be altered via epigenetic editing while ensuring the integrity of the DNA is preserved and no mutations

are introduced.

Think of it as CRISPR disarmed. The function that guides the CRISPR system to a precise location in a genome is still there—it’s just missing the scissors. Instead, molecular switches are used to turn specific genes on and off. The resulting changes aren’t genetic—they’re epigenetic. Taken literally, epigenetic means “above the gene.”

The epigenome tells a genome what to do.

By modifying the epigenome, it’s possible to control how a gene behaves without actually modifying any DNA directly. It’s sort of like gene editing, without actually doing any editing.

To accomplish this, the Salk scientists relied on what’s known as a “dead” form of Cas9.

In the CRISPR system, the Cas9 enzyme is what actually does the cutting. But its dead version doesn’t cut.

The active ingredients this time were transcriptional activation domains in its place, which act like molecular switches to turn specific genes on or off. These are coupled to the dCas9, along with the usual guide RNAs that help them locate the desired section of DNA. There’s just one problem with this technique: normally the CRISPR system is loaded into a harmless virus called an adeno-associated virus (AAV), which carries the tool to the target. But the entire protein, consisting of dCas9, the switches and the guide RNAs, is too big to fit inside one of these AAVs. To work around that issue, the researchers split the protein into two, loading dCas9 into one virus and the switches and guide RNAs into another. The guide RNAs were tweaked to make sure both parts still ended up at the target together, and to make sure the gene was strongly activated.

“We were very excited when we saw the results in mice,” adds Fumiyuki Hatanaka, a research associate in the lab and co–first au-

By Disha Padmanabha The Belmonte lab’s advanced in vivo Cas9-based epigenetic gene activation system enhances skeletal muscle mass (top) and fiber size growth (bottom) in a treated mouse (right) compared with an independent control (left).

The fluorescent microscopy images at bottom show purple staining of the laminin glycoprotein in tibialis anterior muscle fibers.

thor of the paper. “We can induce gene activation and at the same time see physiological changes.”

“There are still multiple steps that need to be examined before applying this method in human patients,” co-first author Hsin-Kai Liao said. “For example, it must be determined whether host immune responses against the AAV-CRISPR/Cas9 Target Gene Activation system arise in mice or large animals. Safety and ethical considerations will

also have to be addressed before bringing this technique to human patients.”

Belmonte and his colleagues are working to expand the new system’s application to different cell and organ types, diseases, and age-related conditions. “Our goal will be to re-activate genes silenced by ageing, or to use the system to replenish stores of adult stem cells, which promote regeneration but are typically depleted with age,” he said.

The team from left: Hsin-Kai (Ken) Liao, Juan Carlos Izpisua Belmonte and Fumiyuki Hatanaka

5

Vol. 01 NO 5

December 19th, 2017.

JOBS 35 + GOVT HOBS @ MINISTRY OF AGRICULTURE & FARMERS WELFARE | RESEARCH ASSOCIATES & SRF POST VACANT Directorate of Plant Protection Quarantine & Storage, (An attached office of Ministry of Agriculture & Farmers’ Welfare) CGO Complex, NH – 4, Faridabad – 121 001.

Subject: Notification for engagement of Research Associates and Senior ResearchFellows on contract basis through walk-in interview: reg.

Walk-in-interview for engagement of 11 Research Associates and 27 Senior Research Fellows purely on contract basis will be held on 23th December 2017 at 10.00 AM at Regional Plant Quarantine Station, Mumbai and Chennai. Other details and terms & conditions can be obtained from public domain; www.ppqs.gov.in.

Applications are invited in the prescribed format (Annexure -I) for engagement of Research Associate (RA) and Senior Research Fellow (SRF), on purely temporary basis in the Plant Quarantine Division of Directorate of Plant Protection, Quarantine & Storage, CGO Complex, NH – 4, Faridabad, Haryana, Pin – 121 001and its sub offices from eligiblecandidates to be filled through walkin interview as per Annexure-II at Regional Plant Quarantine Station, Mumbai and Chennai on 23rd December, 2017. Candidates shall bring original documents along with

attested photocopies of certificates from matriculation onwards, copy of recent passport size photographs and experience certificate.

The vacant positions of RA/SRF are given in Annexure II. Requirement & Eligibility Criteria: Position I Name of the Position : Research Associate No.of.Positions : 11 Required Educational Qualifications : Doctorate Degree in Entomology/ Nematology/ Plant Pathology/Agronomy from a recognized University Position II Name of the Position : Senior Research Fellow No.of.Positions : 27 Required Educational Qualifications : M.Sc. Degree in Entomology/ Nematology/ Plant Pathology/ Botany with specialization in Plant Pathology/Botany with weed science as a subject or Zoology with specialization in Entomology from a recognized University or

M. Sc. Degree in Agriculture with specialization in Entomology/ Nematology/ Plant Pathology/Agronomy from a recognized University Tenure : Up to 31st March, 2018 and the tenure is likely to be extended.

Desirable : Knowledge in computer applications, data organization / report writing/ IT Management.

Emoluments: Research Associates (RA) : Rs.40,000 per month + HRA as per applicable rates. Senior Research Fellow (SRF) : Rs. 25,000 per month + HRA as per applicable rates for 1st and 2nd year and Rs. 28,000/- + HRA as per applicable rates for the 3rd year Age Limit : i. The upper age limit for RAs will be 40 years for Male and 45 Years for Female candidates; ii. The upper age limit for SRFs will be 35 years for Male and 40 Years for Female candidates.

How to Apply: 1. The candidate must bring all original certificates along with attested photocopies of all required certificates from matriculation onwards and copy of recent passport size photographs and experience certificate in original (if any) with them which can be submitted at the time of interview.

2. Concealing of facts or canvassing in any form shall lead to disqualification or termination.

3. The engagement may be terminated at any time without notice or assigning any reason thereof. The RA/SRF may also leave the assignment, on their own volition, by giving one month notice. At the end of the contracted period, the RA/ SRF will have no right to claim any employment or engagement in the Directorate.

4. No TA/DA will be paid for appearing in interview.

5. The candidates are required to submit the applications as per the format annexed (Annexure- I).

Walk-In Details: Date of Interview – 23rd December 2017 Time of Interview – 10.00 AM Venue of Interview – Regional Plant Quarantine Station, Mumbai and Chennai.

CONSULTANT MICROBIOLOGIST POST @ ICMR-RMRC WITH MONTHLY SALARY OF RS. 65,000/A walk-in-interview (written test/interview) is scheduled to be held at the office of ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar – 751023 for recruitment of contractual posts Consultant Microbiologist for project entitled “National Reference Laboratory-TB under Revised National Tuberculosis Control Program (RNTCP)”. Eligible candidates may attend walk in interview on 05.01.2018 at 02:00 PM. Other details like age limit, educational qualification, selection process & how to apply are given below:Job Title : Consultant Microbiologist No.of.Positions : 01 Consolidated Salary : Rs. 65,000/Age Limit : Not exceeding 65 years as on date of interview.

6

Essential Qualification : MD Microbiology or PhD Medical Microbiology or MSc. (Medical or Applied Microbiology) Desirable: Five year of relevant work experience.

Job specification/Responsibilities: - To handle day to day correspondence in National Reference Laboratory pertaining to Culture and DST. - To conduct on-site evaluation of Laboratories under RNTCP and submit periodic reports to CTD. - To implement SOPs in NRL, revision of SOPs as per program need incorporating newer technology.

- Provide technical support in expansion of the full range of activities under the external quality assessment (EQA) for sputum smear microscopy and mycobacterial culture and drug susceptibility testing.

- Support in planning and scaling up of qual-

ity assured mycobacterial culture and drug susceptibility testing (DST) for MDR TB management and drug resistance surveillance.

- To provide on the job training to the laboratory technicians in NRL.To engage maintenance agencies for NRL equipment and monitor their performance.

- To assist and monitor implementation of lab QA in States, in coordination with respective microbiologist (IRL & EQA) for all technologies (LJ, LC, LPA, CBNAAT).

- To coordinate with partner organizations engaged in infrastructure development or culture / DST capacity development of NRL. - To oversee date entry of Direct Microscopy / CDST labs into the TB ICT application (NIKSHAY).

- To provide timely feedback to CTD on performance of laboratories under RNTCP. - To facilitate change management with respect to use of ICT & NIKSHAY tools for concerned data entry, validation & its use for public health action.

- Any other tasks assigned as per program

needs.

How to Apply: Interested candidates possessing the required qualification may attend the walk in interview along with the attached prescribed format and photocopies of the documents/ certificates, CV along with a passport size photograph at ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar- 751023 on above mentioned dates. Applicant should report to the centre between 1:30 PM – 02:00 PM on the specified date.

After scrutiny and verification of original documents eligible candidates will be required toappear for the written test/skill test/ interview.

Walk-In Details: Date of Interview – 05.01.2018 Time of Interview – 1:30 PM – 02:00 PM Venue of Interview – office of ICMR-Regional Medical, Research Centre, Chandrasekharpur, Bhubaneswar – 751023

Vol. 01 NO 5

December 19th, 2017.

40 + JRF POSTS FOR LIFE SCIENCES CANDIDATES @ CSIR-IICB The Institute was established in 1935 as the first non official centre in to carry out basic biomedical research and was taken over by CSIR in 1956. CSIR-IICB today, by its mandate, is engaged in research on diseases of national importance and certain biological problems of global interest.

CSIR-IICB is putting emphasis on quality basic research, on projects having applied potential and is looking forward to a successful Industry-Institute liaison towards closer partnership.

Position : JRF (Direct) No. of Vacancies : 40 Vacancy Code : 5011701 Age Limit : 28 Years.

Field / Research Areas : Chemistry, Organic, Inorganic and Bio organic Chemistry, Synthetic Organic Chemistry, Medicinal Chemistry, Chemical Biology, Nanomaterial & their characterization by biographical studies, Metal catalysis, Neurobiology and Cancer Biology, Bioinformatics, Structural Biology, Life sciences, Infectious Diseases, Plant Sciences, Biotechnology or any branch of Life Sciences.

Qualification required : NET-JRF (CSIR/UGC) examination qualified candidates or DBT/DST-INSPIRE/ ICMR-JRF Fellows having independent fellowship with M.Sc degree in Chemistry / Biology. Students in their final year of M.Sc may also apply, provided they fulfil other

qualifications.

How to Apply: The engagement is purely temporary and, therefore, does not confer any right / claim implicit or explicit for regularization or absorption against any IICB / CSIR post. The age and qualifications will be reckoned as on the date of interview. The upper age limit is relaxable for SC / ST / OBC / PH and women candidates as per rules. The interview may be carried over to the next day (i.e. 04.01.2018) if there are more candidates. So candidates are requested to plan their programme accordingly. Interested candidates fulfilling all the above conditions may appear for the walk-in-interview to be held on 03.01.2018 from 9.30 AM in the Conference Room with the following documents (original as well as self attested copies) – (1) Matriculation

Certificate in support of your date of birth, (2) Degree/Diploma Certificate, (3) Original reprints of all testimonials regarding educational qualifications, (4) No objection certificate from the employer if employed, (5) Final Marksheet of M.Sc. Examination, (6) Documentary evidence of qualifying NET examination, (7)One recent passport size photograph. (Candidates selected through this interview would be encouraged to register for Ph.D in AcSIR) Walk-In Details: Date of Interview – 03.01.2018 Reporting Time – from 9.30 A.M. to 10.30 A.M Venue of Interview – Conference Room

BPSGMC RECRUITMENT 2017 - RESEARCH SCIENTIST POST | SALARY OF RS. 60,000/- P.M. BPSGMC for Women, Khanpur Kalan, Sonepat invites applications for filling up the following post as per prescribed eligibility & salary fix p.m. mentioned below in ICMR/ DHR sanctioned project entitled to develop a Medical College level Virology Research & Diagnostic Laboratory (VRDL) Position I Name of the Position : Research Scientist (Non-Medical)

solidated Qualifications & Experience : MSc in (Virology/ Microbiology/ Biotechnology/ Molecular Biology/ Medical Microbiology/ Life Sciences) from a recognized university with 3 years research experience.

Or PhD in the above subjects.

(Knowledge of computer applications / Data management desirable)

No.of.Positions : 01

Position II

Monthly Emoluments : Rs. 60,000/- con-

Name of the Position : Research Scientist

No.of.Positions : 01 Monthly Emoluments : Rs. 30,000/- consolidated

Qualifications & Experience : MSc in (Virology/ Microbiology/ Biotechnology/ Molecular Biology/ Medical Microbiology/ Life Sciences) from a recognized university.

• Preference will be given to the candidate having experience in ICMR/DHR/ IDSP/CSIR any project / Medical col-

•

lege / Govt Institute.

Knowledge of computer applications / Data management desirable

How to Apply: Candidates fulfilling the prescribed eligibility to submit an application along with bio-data and attested photographs of the certificates to the Director Officer, Bhagat Phool Singh Govt. Medical College, Khanpur, Kalan, Sonepat by 30.12.2017.

Candidates are required to appear for the interview on 10.01.2018.

7

Vol. 01 NO 5

December 19th, 2017.

PHD BIOLOGICAL SCIENCES RESEARCH POST @ NII - NATIONAL INSTITUTE OF IMMUNOLOGY Applications are invited for the position of Research Associate (RA) for the following time-bound sponsored project as per the details given below: Job Title : Research Associate Project Title : “Functional characterization of an Immunomodulatory protein in Plasmodium” funded by SERB Principal Investigator : Dr. Agam Prasad Singh Staff Scientist-V ( singhap@nii. ac.in ) Emoluments : The selected candidates will draw consolidated emoluments as per Institute Rules, depending upon qualifications & experience

Rs. 36,000/- to Rs. 38,000/- per month plus 30% HRA (As per DST OM dated 21.10.2014) Educational Qualifications : Ph.D in Biological Sciences. Candidates with work experience in the field of Immunology, Molecular Biology or Host Pathogen Interaction will be given preference.

Job description & Desired Knowledge: Immunoassays, FACS, Animal Immunization, challenge with Plasmodium, Protein expression, Plasmodium knockout: parasite generation and characterization.

Terms & Conditions: 1. The candidates selected for the above posts will be on contract for one year or duration of the project whichever is shorter, at

a time.

2. No hostel/ housing facility will be provided.

3. Applicants may clearly mention the category they belong to i.e. SC/ST/OBC/PH and attach documentary proof of the same.

4. No TA/DA will be paid for attending the interview, if called for.

5. Apart from sending application in the prescribed format given below, candidates should send complete Curriculum Vitae along with the names of three referees. Curriculum Vitae should contain details of the experimental expertise and list of publications.

6. Canvassing in any form will be a disqualification.

How to Apply:

MAT GIVEN BELOW, through E-mail, to the Investigator of the project, clearly indicating the name of the project along with their complete C.V., E-mail-ID, fax numbers, telephone numbers. Only Short listed candidates will be called for interview and they required to submit attested copies of all their certificates and a Demand Draft of Rs 100/- drawn on Canara Bank or Indian Bank payable at Delhi/New Delhi in favour of the Director, NII (SC/ST/PH and Women candidates are exempted from payment of fees) subject to submission of documentary proof), at the time of interview LAST DATE OF RECEIPT OF APPLICATIONS: 29th December, 2017

Interested candidates may apply directly, STRICTLY IN THE PRESCRIBED FOR-

POST DOCTORAL POSITION @ BIOTECH DEPT. - IIT ROORKEE | FELLOWSHIP OF 55,00/- P.M. The Department of Biotechnology at the Indian Institute of Technology (IIT) Roorkee invites applications from outstanding and enthusiastic researchers for post doctoral position under the mentorship of Dr. Ranjana Pathania. Associate professor, focused on “Molecular Biology, Biotechnology, Molecular microbiology and Microbial genomics” to work on “Determining Novel sRNA and Hfq interactions that mediate antibiotic resistance in Acinetobacter baumannii” The prospective candidate is expected to have a strong background in one or more areas within Biotechnology,Molecular Biology, pharmacology, Microbiology and chemical benetics. candidate should be passionate about working on cutting edge research leading to high impact publications and products’ Name of the Position : Post Doctoral Fellowship (PDF) Minimum qualifications and experience:

8

a) Essential qualifications* The prospective candidate should have PhD in Biotechnology/Molecular Biology/Microbial Genomics / Molecular Microbiology with first class in the preceding degree. b) Desirable qualifications 1 or 2 years of experience/ specialization in recombinant DNA technology, Genomics, RNomics, Bioinformatics, Next Generation Sequencing OR preferable PhD in these areas. The prospective candidate should have at least two SCI publications in the area of Biotechnology/Molecular Biology / Pharmacology. *Candidates who have recently, submitted their doctoral thesis are also eligible to apply subject to the condition that they will furnish the proof of award of Ph.D. at the time of interview.

Duration & Fellowship Amount: The duration of the fellowship will be of

two years extendable to one more year, if necessary. The candidate is expected to join the department as soon as the offer letter has been released. The fellow will receive a consolidated pay as below in addition to the contingency grant of Rs. 20,000/- per annum.

First year: Rs. 50,000/- per month Second year: Rs. 55,000/- per month How to Apply: Candidates can apply with a cover letter, curriculum vitae, list of publications (with their respective impact factor), and research statement describing past research and plans for future research, by both regular (Speed post) and e-mail to : Professor and Head Department of Biotechnology Indian Institute of Technology Roorkee Roorkee-247667

India Email: biotech@iitr.ac.in (and copy to rpathfbs@gmail.com) Phone : +91-1332-285216/284316/285677 Fax : +91 – 1332-286151 Notes: (i) All the post doctoral fellows (PDF) will be registered as IIT Roorkee students for availing the facilities of accommodation, hospital, medical insurance scheme, computer center, library, sports, etc. (ii) The candidates called for presentation/ discussion/interview will be paid II-AC train fare from their place of residence/work and back by the shortest route within India Last date for submitting the soft copy and hard copy of the application is December 18th, 2017 (5:00 PM). Applications received after this date will not be considered.

Application Deadline – December 18th, 2017 (5:00 PM)

Vol. 01 NO 5

December 19th, 2017.

SCHOLARSHIP/AWARDS

Applications Invited For “Young Researcher Award – 2018” Applications are invited for the “Young Researcher Award – 2018” This Scheme is instituted by the Trust to recognize and reward young Indian scientists, below the age of 40 years, with outstanding track record in biological sciences, a deep commitment to find innovative solutions to major problems related to human diseases and potential for high quality research.

Applicants must have a regular position in a University / Organization / Institute in India and should be engaged in research and development and have publications arising from research done as an independent investigator in India.

Application form along with separate summary sheets may duly be submitted online on www.ladytatatrust.org by the host institute as per pro forma given on site OBJECTIVES: The aim is to reward Young Researchers (< 40 years) who have displayed a potential for high quality research.

SCOPE: All areas of Life Sciences and Biotechnology related to human diseases will be covered by this Award.

ELIGIBILITY: i) The Award is open to Indian Nationals, residing in India, who are below the age of 40 years as on 31st March 2018. ii) The applicant should possess a Ph.D. degree in any Biological Science or a Master’s degree in Medical Sciences, or an equivalent degree in Biotechnology related areas. The applicant must have at least 4 years’ professional experience in the specific area after obtaining the above degree. iii) The candidate must have a regular position in a University / Organization / Institute in India. He/she should be engaged in research and development and have publications arising from research done as an independent investigator in India. The awardee will be eligible for regular research grants through extramural and other research schemes of various S & T agencies of the Government of India.

ABOUT THE AWARD : The amount of the Award will be Rs.25,000/per month in addition to regular salary from the host institute.

In addition, the Young Researcher will receive a contingency grant of Rs.5.00 lakhs per annum for meeting the expenses on consumables, minor equipment, international and domestic travel, manpower and other contingent expenditure to be incurred in connection with the implementation of research project under the Award. All bills and receipts should be send to the LTMT office every six month, after purchase of any items from contingency grant.

HOST INSTITUTION: The Institution where the candidate is working will provide the necessary infrastructure and administrative support for pursuing research under this Award.

DURATION: The duration of the Award will be initially for three years, extendable further by two years, on a review by the Trust’s Experts’ Committee.

PROCESSING FEE : A Demand Draft of Rs.500/- being Processing Fee (non-refundable) should be forwarded in favour of the Lady Tata Memorial Trust, and the DD should be scanned and forwarded along with the online application form Please note that :The candidate must forward the application through the Director of a recognised Research Institute or Laboratory where he / she proposes to work.

The application should be addressed to The Secretary, Lady Tata Memorial Trust, Bombay House, 24 Homi Mody Street Mumbai 400 001, and submitted online on our website not later than 15th January 2018.

The selected applicants will be called for an interview in the middle / third week of March/ April 2018 and based on personal interview, one young researcher will be awarded and announced by the end of March/April 2018.

The selected Researcher will be required to commence research effective 1st April/May 2018.

Applicants must comply with the above instructions strictly. An application will not be considered if the candidate fails to furnish the requisite information and supporting documents, certificates and letters.

Any misbehaving, arguments, canvassing, direct or indirect, will entail disqualification.

• • • • • • • • •

Cambridge International Scholarships For Undertaking PhD / M. Phil Studies – A Biotecnika Exclusive On behalf of the University, the Cambridge Trust is pleased to offer the Vice-Chancellor’s Awards (for UK and EU students) and the Cambridge International Scholarships (for international students) for those undertaking PhD studies.

The aim of the Vice-Chancellor’s Awards and Cambridge International Scholarships is to ensure that the 250 highest ranked students, irrespective of nationality, receive full financial support to undertake research leading to a PhD. The Scholarships pay the University Composition Fee and a maintenance allowance sufficient for a single person.

Applicants who wish to start their PhDs in 2018-19 must apply by 6 December 2017 or 4 January 2018, whichever deadline is appropriate for your course.

• •

Note : •

•

•

•

Please see the Graduate Admissions webpage ‘Application & Funding Deadlines’.

Courses Offered : • • • • • • • • • • • • • • • • • • • •

PhD in Animal Health PhD in Biochemistry PhD in Biological Science (Babraham Institute) Mphil in Biological Science (Biochemistry) PhD in Biological Science (EBI) Mphil in Biological Science (Genetics) Mphil in Biological Science (MRC Cognition and Brain Sciences Unit ) PhD in Biological Science (MRC Cognition and Brain Sciences Unit ) Mphil in Biological Science (MRC Mitochondrial Biology Unit ) PhD in Biological Science (MRC Mitochondrial Biology Unit ) PhD in Biological Science (MRC Toxicology Unit ) Mphil in Biological Science (Pathology ) Mphil in Biological Science (Pharmacology ) Mphil in Biological Science (Physiology, Development and Neuroscience) Mphil in Biological Science (Plant Sciences) Mphil in Biological Science (Psychology) PhD in Biological Science (Sanger Institute) Mphil in Biological Science (Sanger Institute) M.Phil in Biological Science (Zoology) BBSRC DTP PhD in Biological Sci-

ence M.Phil in Biosciences Enterprise PhD in Biostatistics PhD in Biotechnology M.phil in Biotechnology PhD in clinical Biochemistry Wellcomne Trust PhD Programme for Clinicians PhD in Clinical Neuroscience M.Phil in Computational Biology Mphil + PhD in Developmental Biology PhD in Zoology + Much More

•

•

All applicants should complete the funding section of the online application form via the Applicant Portal expressing their ‘wish to be considered for funding’.

A University Committee draws up one ranked list of all PhD candidates across all disciplines. The only factors taken into consideration in agreeing this list are academic qualifications, references and research potential. The financial situation of applicants does not affect the selection of scholarship winners.

Successful applicants are informed at the earliest opportunity and the Trust will announce the winners of the Cambridge International Scholarships for 2018-19, and the winners of the Vice-Chancellor’s Awards for that year, in early March 2018.

In order to maximise the number of Scholarships awarded, the Trust will, when appropriate, promote winners of Vice-Chancellor’s Awards and Cambridge International Scholarships to other full-cost awards with UK Research Councils, or partner organisations, or Departments or Colleges, who are willing to provide either the full amount or part of the cost of the scholarship. Where part of the cost of a scholarship is offered, the Trust will meet the balance.

In the case of students securing other full-cost scholarships, the Trust will be pleased to offer ‘honorary’ status which entitles them to become a Trust scholar without remuneration.

The scholarships are awarded early in the academic year. You will be informed in March 2018 if you are have been successful in gaining a scholarship, following meetings of the Selection Committee.

How to Apply : We advise all applicants to apply as early as possible. You should not wait until the day of the deadline to submit your application or supporting documents.

If you are applying for funding, there are two deadlines to consider: •

The course deadline

All courses have a deadline beyond which applications cannot normally be considered.

However, you should not wait until the day

Next Page>>>> 9

Vol. 01 NO 5

December 19th, 2017. of the deadline to submit your application or supporting documents as there is no guarantee that places will still be available at that point. If a course closes early, the course directory will be updated accordingly. Occasionally deadlines for some subjects will be extended so do check the deadline below as you may still be able to apply even if an earlier deadline has passed.

•

The funding deadline

Funding Opportunities There are many funding opportunities at Cambridge from a wide variety of sources including the Cambridge Trust, Gates Cambridge, Colleges, departments, Research Councils and central University funds. You can use our Cambridge Funding Search page to find out which type of funding you might be eligible for, and how and when to apply.

We also operate a Graduate Funding Competition to co-ordinate some of these funding opportunities and make the process easier for you as an applicant.

How to Apply It is easy to apply for funding at Cambridge.

Eighty per cent of the funding awarded to applicants last year was from competitions that just require you to complete the funding section of the Graduate Application Form (via the Applicant Portal); you will be able to check using our funding search for options that you aren’t automatically considered for.

The most important thing to remember is this: get your applications in early! See below for deadlines.

other scholarships in the Cambridge Funding Search (note that some of these may be earlier than those listed below).

Application for both is via the same online form but you must apply by whichever deadline comes first. Which this will be depends

Please note these deadlines are for applicants for courses starting in Michaelmas 2018, Lent 2019 and Easter 2019. Students starting their courses in Lent or Easter 2018 are no longer eligible for the Graduate Funding Competition.

on the course and your status as explained below.

When will I hear?

Most funding awards are made between the beginning of March and the end of July with the majority of awards being made in March and April. If you haven’t heard by the end of July, you should assume that your application for funding has been unsuccessful.

Funding Deadlines The deadlines for the Graduate Funding Competition (including Gates Cambridge) are listed below. You can find deadlines for

It is also worth keeping an eye on the news updates on the Graduate Admissions Homepage for the latest information on awards being offered.

Please note All deadlines for the submission of the application are 12:00pm (midday) UK timeon the date stated.

You must provide all supporting documents at the same time as the rest of your application.

ADMISSONS nology / Bioprospection / Genomics / Plant Tissue Culture / Bioinformatics / Plant Physiology / Metabolomics / Biochemistry / Microbiology / Botany and Pharmacogonosy / Natural Product/Synthetic / Analytical / Process Chemistry / Pharmaceutical Industrial Chemistry / Chemical Engineering / Agronomy / Soil Science / Agriculture-microbiology / Plant Nutrition / Crop Improvement / Crop Protection / Agricultural Economics & Extension / Environmental Sciences, etc.

CIMAP-JNU Ph.D. Programme (2018-2019) CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) is a constituent laboratory of Council of Scientific and Industrial Research (CSIR), which is an autonomous body under the Ministry of Science & Technology, Government of India. The Institute conducts research in all frontline areas of Biological, Agricultural & Chemical Sciences.

The institute invites eligible candidates for admission in CIMAP-JNU Ph.D. programme (2018-2019) leading to award of Ph.D. degree from Jawaharlal Nehru University, New Delhi.

The selected candidates will be enrolled for Ph.D. programme in academic affiliation with the Jawaharlal Nehru University, New Delhi. Reservations are as per statutory of India norms.

The selected candidates will have to complete Pre-Ph.D. courses in any one sub-disciplines of their interest as the core courses with optional courses, in two semesters spread over one year. On the successful completion of courses (OGPA 6.5/10.0 for general & OBC category and 6.0/10.0 for SC/ ST//PH) students will be eligible for registration as CIMAP-JNU Ph.D. scholar under the supervision of CSIR-CIMAP scientists available as guide to carry out research on a scientific topic covered under above areas at CSIR-CIMAP.

10

•

Walk-In Details: Date of Interview – 03-01-2018 Time of Interview – 10:00 AM Venue of Interview – CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow.

•

•

Admission to the CIMAP-JNU Ph.D. programme (January 2018) will be made purely based on a written test followed by interview. Walk-in-interview is scheduled to be held on 03-01-2018 at 10:00 AM at CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow.

Before interview, candidate has to fill an application from which must be accompanied with nonrefundable processing fee in the form of a Demand Draft for Rs.200/- (Rupees two hundred only) for General candidate and Rs.100/- (Rupees hundred only) for SC / ST / OBC / PH candidate fee drawn in favour of Director, Central Institute

als for the PhD programme in various areas of biological sciences viz. Biodiversity & Palaeobiology, Bioenergy, Bioprospecting, Developmental Biology, Genetics & Plant Breeding and Nanobiosciences. Interested candidates are advised to visit ARI webpage (www.aripune.org) for detailed information and may send their application (only by email) to phdadmission@aripune.org in prescribed format available at ARI website (www.aripune.org).

Essential Qualifications: M.Sc. (any branch of biological science) or equivalent qualification with minimum 60% marks (or equivalent grade point). Must have qualified CSIR /UGC-Junior Research Fellowship OR NET-LS/GATE/SPPU-PET and fellowship from ICMR/INSPIRE/DBT. Important Dates: Last date of receiving applications by email: 31st December, 2017 List of shortlisted candidates will be displayed on ARI website: 10th January, 2018.

Note:

Application Procedure:

Eligibility: Candidates who have completed M.Sc. in Life Sciences / Agriculture / Botany /Chemistry / Biotechnology / Bioscience / Biochemistry / Plant Sciences / Environmental Sciences / Molecular Biology / Bioinformatics with minimum 55% marks (50% marks for SC/ST/PH) and have cleared CSIR-UGC NET Exam/ICMR-NET Exam / DBT-JRF Exam or any other Exam leading to JRF/SRF fellowship tenable at CSIR-CIMAP are eligible to apply under the programme to carry out advanced research in the area of Biotech-

•

of Medicinal and Aromatic Plants, Lucknow. Application proforma can be downloaded from our website www. cimap.res.in. Candidates have to bring all the academic / educational certificates and proof of award of fellowship in original.

Application should be accompanied by attested copies of certificates and mark sheets from senior secondary level onward.

CSIR-CIMAP will not provide any accommodation and travel expenses to candidates appearing for interview.

Ph.D Biological Sciences 2018 Admissions @ MACS-ARI, Pune MACS-Agharkar Research Institute, Pune 411004 (An autonomous Institute of the Department of Science and Technology, Government of India) Ph.D. ADMISSIONS 2018 Applications are invited from Indian nation-

The email subject should mention “Last Name_Application for Ph.D. Programme” No TA/DA will be provided for attending the interview.

Interview will be conducted on 30th January, 2018, 10 a.m. at Agharkar Research Institute, GG Agarkar Road Pune – 411004, Maharashtra.

Application Deadline – 31st December, 2017

Vol. 01 NO 5

PhD Admissions 2018 @ University of Madras

The Degree of Doctor of Philosophy (Ph.D.) is awarded to a candidate who, as per these regulations, has submitted a thesis on the basis of original and independent research in any particular discipline or involving more than one discipline (inter-disciplinary), that makes a contribution to the advancement of knowledge, which is approved by Board of examiners as required.

Eligibility: For purposes of admission to the Ph.D. programme, a candidate should have obtained a Master’s Degree with 55% marks in the qualifying examination.For SC/ST candidates and for candidates who have completed the PG degree before 1991, the minimum can be only 50% for admission to the Ph.Dprogramme.

Registration for the PhD Programme: There shall be the following categories of candidates registered for the Ph.D. programme: a. Full-time scholar (with or without stipend or fellowship) b. Part-time scholar (teacher or non-teacher, internal vis-à-vis external) The candidates belonging to any of the above categories may register at University Departments, Affiliated Colleges, Research Institutions, or R & D Centres/Laboratories coming under these regulations.

FULL-TIME The following candidates are eligible to register for the full-time Ph.D. programme. A candidate who has qualified for: a. Master’s Degree in the faculties of Arts, Sciences, Fine Arts, Languages, Commerce, Education, Management Science of this University or equivalent thereto PART-TIME (INTERNAL) A candidate, possessing any one of the qualifications prescribed under Regulation 2 supra and falling under any of the following categories, is eligible to conduct research on a Part-time basis (i.e., can conduct research while continuing as teacher, Executive etc.): a. A teacher working in the Department of the University or in an affiliated College of the University, Higher Secondary School or High School or Polytechnic within the territorial jurisdiction of the University provided b. Teachers of affiliated colleges holding NET/SLET qualification or M.Phil. degree with one year of teaching experience after M. Phil degree and Teachers of Higher Secondary Schools/High Schools and Polytechnic

December 19th, 2017. with two years of experience after the qualifying degree be allowed to register for Ph.D (part-time) programme. c. Teachers of affiliated colleges in the following disciplines, with one year of teaching experience without M.Phil or SLET/NET are permitted to do part-time Ph.D i) Computer Science, ii) Media Arts, iii) English, iv) Management, v) Natya, vi) Communication and Journalism, vii) Hotel and Catering Management, viii) Interior Design, ix) BioTechnology and x) Bio-Informatics. d. A candidate employed other than as a teacher in a permanent job in a registered firm/institution, within the territorial jurisdiction of the University with a minimum of FOUR YEARS of total working experience, after the qualifying degree and satisfying the rules framed separately by the Syndicate from time to time. e. Research Assistants/Technical Assistants appointed on a permanent basis by the University are eligible to register for Ph.D. programme on Part-time basis after confirmation of service. f. Candidate with M.L. Degree practicing as an advocate in any Court of Law or serving as a Legal Advisor to/in a registered firm/institution within the territorial jurisdiction of the University with a minimum of FOUR YEARS of total working experience after qualifying degree.

PART-TIME (EXTERNAL) Not withstanding anything contained in these regulations, candidates possessing anyone of the qualifications from the University of Madras or from any other University recognized by the Syndicate as equivalent thereto, prescribed under Regulation 3.2 supra, and employed as a teacher, scientist or in any other related capacity (as recommended by the Selection Committee of the concerned department) in National/State level institutions, Universities, Research and Development (R&D) Centres/Laboratories and institutions outside the territorial jurisdiction of this University, in India and abroad, who are permitted by the respective organizations for pursuing research leading to the Ph.D. Degree of this University on a Part-time basis, while continuing in employment, may be permitted to register for the Ph.D. programme on a Part-time basis as external candidates two years after acquiring qualifying degree.

These candidates are expected to do research in their place of employment and in addition, they should undergo such course work, examination and research work as may be prescribed by the supervisor/doctoral committee for a minimum of SIX MONTHS during the research period directly under the supervisor in this University. In addition to the Supervisor from this University, they shall have a joint supervisor from the institution where they are employed, provided such a supervisor is recognized as supervisor for Ph.D. programme by this University or the host University. In the case of non-availability of a recognized supervisor in the institution, the candidate’s research work shall be monitored by the Head of the institution.

DURATION OF RESEARCH FULL-TIME A candidate registered as a full-time scholar for the Ph.D. programme possessing any one of the above qualifications as mentioned in Section 3 supra shall work continuously in the department under a supervisor for a minimum period of THREE YEARSafter provisional registration and before submission of

the thesis.

PART-TIME A candidate registered for the Ph.D. programme as a part-time scholar (both internal and external) shall work for a minimum period of FOUR YEARSafter provisional registration, before submission of the Thesis.

EXEMPTION Exemption of ONE YEARfrom the minimum duration required is permissible in respect of candidates who possess an M. Phil./M.Phil.on INTER-DISCIPLINARYbasis or M.Litt. (in the relevant subject) or Master’s Degree in the faculty of Law, M.E and M.Tech.

CONVERSION OF FULL-TIME REGISTRATION INTO PART-TIME AND VICE-VERSA Notwithstanding anything prescribed in these regulations, the University may permit conversion from Full-time research to Parttime research and vice-versa in respect of candidates registered, for valid reasons and subject to satisfying the regulations, rules and conditions in force. The period put in by the candidate will be worked out in the ratio of 2:3 for research put in before and after such conversion.

How to Apply: Admissions for Ph.D. programme can be made four times in a year, i.e., January, April, July and October. Applications can be downloaded from the University websie and submit the same with processing fee of Rs.500/(fee exempted for SC / ST) The application forms will be available during the months of December, March, June and September every year for admitting the candidates for four sessions. Candidates should submit their applications on or before the first working day of a quarter, viz., January, April, July and October. Admission to Ph.D. programme shall be completed in the first month itself in each session. Registrations for Ph.D. may be done throughout the year

Pursue Doctoral Research Leading to PhD in Biomedical Genomics @ NIBMG Pursue Doctoral Research @ NIBMG – National Institute of Biomedical Genomics INFORMATION FOR STUDENTS INTERESTED TO PURSUE DOCTORAL RESEARCH IN BIOMEDICAL GENOMICS, INCLUDING STATISTICAL GENOMICS, AT THE NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS (NIBMG), KALYANI

NIBMG is accepting applications from eligible candidates to pursue doctoral research, leading to a PhD degree, in the disciplines of Biomedical Sciences at the institute under the mentorship of NIBMG faculty. Research on Biomedical Genomics encompasses research on all aspects of genetics and genomics in relation to human health and disease, as well as validation by cellular and molecular biology methods. A typical PhD student would get opportunity to be trained in the cutting-edge laboratory technologies as well as computational and statistical techniques. NIBMG is currently engaged in several multi-center collaborations and hence the students will have exposure to inter-institutional environment. Specific projects will have lot of interdisciplinary components.

The broad areas of research on which students are expected to work are listed below: 1. Cancer Genomics and Epigenomics 2. cenomics and Epigenomics of Complex Human Diseases (including Microbiome Biology) 3. Genomics and Epigenomics of lnfectious Disease Biology 4. Systems Biology and Computational Biology 5. Statistical Genomics 15% OF THE SEATS ARE RESERVED FOR THE SC CATEGORY, 7.5% FOR THE ST CATEGORY AND 27% FOR NON-CREAMY LAYER OBC CATEGORY. CERTIFICATES FROM RELEVANT AUTHORITIES ARE TO BE PROVIDED AS PROOF BEFORE THE INTERVIEW. The minimum eligibility criteria for accepting students at NIBMG to pursue research leading to Ph.D. degree are: Master’s degree in a relevant discipline (Biochemistry, Biotechnology, Molecular Biology, Genetics, Statistics, Bioinformatics, Zoology, Physiology, Biophysics or related disciplines).

Candidates in general category must have secured at least 55% aggregate in Master’s degree. This will be relaxed for reserved categories as they are only required to successfully complete Master’s degree.

An applicant should have passed the NET conducted by CSlR/UGC/lCMR/DBT/ NBHM AND must have a valid award letter of Junior Research Fellowship from CSIR, UGC, ICMR, DBT, NBHM. Candidates who have qualified for Rajiv Gandhi National Fellowship or any other fellowship for the reserved categories are encouraged to apply.

Preference will be given to candidates with demonstrable research training in the form of summer training or short-term courses in established research laboratories in preparation for a research career In biomedical sciences. This condition is not applicable to individuals belonging to reserved categories.

How to Apply: Please apply online via web link http://apply.nibmg.ac.in/ (no other form of application will be accepted). Please indicate online whether you belong to a reserved category or the general category. Online application will be accepted until 5 PM of 31st December, 2017. Short-listed candidates will be called for a formal interview.

Application Deadline – 5 PM of 31st December, 2017

11

Vol. 01 NO 5

December 19th, 2017.

www.biotecnika.org

12